Ligand validation:6FCL

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 6FCL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FCL_AMP_A_200	86%	39%	0.091	0.959	0.9	1.47	1	2	0	0	100%	1
6FCL_AMP_B_200	85%	37%	0.096	0.961	0.96	1.51	1	3	2	0	100%	1
1ORE_AMP_A_1001	99%	34%	0.056	0.988	1.04	1.56	2	2	0	0	100%	1
6FD6_AMP_B_201	97%	37%	0.061	0.978	0.95	1.5	2	3	2	0	100%	1
1ZN8_AMP_A_1031	94%	23%	0.071	0.971	1.32	1.83	3	9	0	0	100%	1
6FD5_AMP_A_201	91%	43%	0.078	0.963	0.82	1.37	1	2	0	0	100%	1
1ZN9_AMP_B_1031	78%	21%	0.111	0.955	1.13	2.14	2	9	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
5VEO_AMP_A_524	100%	40%	0.046	0.987	0.86	1.47	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.